Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Charles Biscotti
RNA Immune Signatures From Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers
Cancers
Cancer Research
Oncology
Related publications
Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma
Journal of Oncology
Oncology
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
Frontiers in Genetics
Genetics
Molecular Medicine
New in High Grade Serous Ovarian Cancer Treatment
Effective Pharmacotherapy
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
PLoS ONE
Multidisciplinary
Integrated Analysis to Identify Molecular Biomarkers of High-Grade Serous Ovarian Cancer
OncoTargets and Therapy
Oncology
Pharmacology
High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer
Frontiers in Oncology
Cancer Research
Oncology
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Small RNAs and the Competing Endogenous RNA Network in High Grade Serous Ovarian Cancer Tumor Spread
Oncotarget
Oncology
Thrombocytosis and Hyperfibrinogenemia Are Predictive Factors of Clinical Outcomes in High-Grade Serous Ovarian Cancer Patients
BMC Cancer
Cancer Research
Oncology
Genetics